Oxazepam and temazepam attenuate paroxetine-induced elevation of serotonin levels in guinea-pig hippocampus

International Journal of Neuropsychopharmacology

Volumn 13, Issue 6, 2010, Pages 807-811

  Cremers, Thomas I F H ^a,b   Dremencov, Eliyahu ^a,b   Bosker, Fokko J ^c   Westerink, Ben H C ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b CHARLES RIVER LABORATORIES   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Hippocampus; microdialysis; oxazepam; selective serotonin reuptake inhibitors (SSRIs); temazepan

Indexed keywords

OXAZEPAM; PAROXETINE; SEROTONIN; TEMAZEPAM; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; SEROTONIN UPTAKE INHIBITOR;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR SPACE; GUINEA PIG; HIPPOCAMPUS; IN VITRO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECTS; DRUG INTERACTION; METABOLISM; PROCEDURES; TIME;

ANALYSIS OF VARIANCE; ANIMALS; DRUG INTERACTIONS; GABA MODULATORS; GUINEA PIGS; HIPPOCAMPUS; MALE; MICRODIALYSIS; OXAZEPAM; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TEMAZEPAM; TIME FACTORS;

EID: 77957102455     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114570999109X     Document Type: Article

References (19)

1. Bordet R, Thomas P, Dupuis B (1998). Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial (Reseau de Recherche et dExperimentation Psychopharmacologique). American Journal of Psychiatry 155, 1346-1351.
2. Breimer DD, Jochemsen R, von Albert HH (1980). Pharmacokinetics of benzodiazepines. Short-acting versus long-acting. Arzneimittelforschung 30, 875-881.
3. Carvalho AF, Cavalcante JL, Castelo MS, Lima MC (2007). Augmentation strategies for treatment-resistant depression: a literature review. Journal of Clinical Pharmacy and Therapeutics 32, 415-428.
4. Cremers TI, Wiersma LJ, Bosker FJ, den Boer JA, et al. (2001). Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? Biological Psychiatry 50, 13-21.
5. Dremencov E, Gur E, Lerer B, Newman ME (2003). Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Progress in Neuro-Psychopharmacology & Biological Psychiatry 27, 729-739.
6. Gallager DW (1978). Benzodiazepines: potentiation of a GABA inhibitory response in the dorsal raphe nucleus. European Journal of Pharmacology 15, 133-143.
7. Gregor KJ, Way K, Young CH, James SP (1997). Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen? Journal of Affective Disorder 46, 59-67.
8. Kennedy SH (2006). A review of antidepressant treatments today. European Neuropsychopharmacology 16 (Suppl. 5), S619-623.
9. Lista A, Blier P, de Montigny C (1989). In vivo presynaptic modulation of serotonergic neurotransmission in the rat hippocampus by diazepam. European Journal of Pharmacology 171, 229-231.
10. Lista A, Blier P, de Montigny C (1990). Benzodiazepine receptors modulate 5-hydroxytryptamine neurotransmission in the rat hippocampus: in vivo electrophysiological evidence. Journal of Pharmacology and Experimental Therapeutics 254, 318-323.
11. McElnay JC, Jones ME, Alexander B (1982). Temazepam (Restoril, Sandoz Pharmaceuticals). Drug Intelligence & Clinical Pharmacy 16, 650-656.
12. Mertens C, Pintens H (1988). Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin. Acta Psychiatrica Scandinavica 77, 683-688.
13. Mongeau R, Blier P, de Montigny C (1997). The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Research. Brain Research Reviews 23, 145-195.
14. Moore N, Verdoux H, Fantino B (2005). Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. International Clinical Psychopharmacology 20, 131-137.
15. Nemeroff CB, DeVane CL, Pollock BG (1996). Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry 153, 311-320.
16. Pei Q, Zetterstrom T, Fillenz M (1989). Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology 28, 1061-1066.
17. Pineyro G, Blier P (1999). Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacological Reviews 51, 533-591.
18. Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, et al. (2007). Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients. Clinical Therapeutics 29, 2319-2332.
19. Youssef NA, Rich CL (2008). Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. Annals of Clinical Psychiatry 20, 157-169.